Equitable access to Covid-19 vaccines is vital in ensuring that every individual has the right to enjoy the best attainable state of physical and mental health in the context of the current pandemic. But pharmaceutical companies continue to prioritize supplying high-income countries who are also stockpiling more doses than they can use, while blocking attempts to increase supplies by supporting the temporary waiver of intellectual property rights and increased sharing of technology and know-how. To date, less than 8% of people in Africa have been fully vaccinated against Covid-19
